Lin. Pattern of impairment status in leprosy related disability during & after anti-leprosy treatment, Bago District (2006-2008). [Amsterdam]: KIT; 2010. p. 51 p.

Tuberculosis and Leprosy Control: WHO Consultation. Weekly epidemiological record [Internet]. 1983;58(15). Available from: http://apps.who.int/iris/bitstream/handle/10665/224428/WER5815_109-112.PDF?sequence=1&isAllowed=y

Anten. Some considerations regarding the evaluation of an East Afrcan leprosy control scheme, with special reference to operational aspects. [Antwerp]: Institute for Tropical Medicine Prince Leopold; 1972. p. 61 p.

Chambers. The integration of leprosy into the general health services in the east central state of Nigeria. [Amsterdam]: Royal Tropical Institute; 1975. p. 38 p.

Naafs. The prevention of permanent nerve damage in leprosy. [Amsterdam]: Universiteit van Amsterdam; 1980. p. unnumbered p.

Rozema. Op goede voet met lepra: de aspecten en problemen bij de behandeling van de voeten van leprapatienten. [Deventer]: Akademie voor Fysiotherapie; 1983. p. 96 p.

Jesudasan. The epidemiological and curative consequences of treatment in leprosy. [London]: London School of Hygiene and Tropical Medicine; 1982. p. 387 p.

Evers. De ziekte van Hansen, deformiteiten aan hand en voet: oorzaak en gevolg. [Amsterdam]: Vrije Universiteit Amsterdam; 1984. p. 93 p.

Batelaan, Rhebergen. Defaulting in Leprosy Treatment: A Retrospective Case-Control Study, Biratnagar, Nepal. [Amsterdam]: Vrije Universiteit Amsterdam; 1996. p. 80 p.

Trao. Dynamics of immune responses in leprosy patients during treatment. [Utrecht]: Utrecht University; 1997. p. 151 p.